The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon

Xiao Yan Wang, Shyama Masilamani, Jakob Nielsen, Tae Hwan Kwon, Heddwen L Brooks, Søren Nielsen, Mark A. Knepper

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

The kidneys "escape" from the Na-retaining effects ofaldosterone when circulating levels of aldosterone are inappropriately elevated in the setting of normal or expanded extracellular fluid volume, e.g., in primary aldosteronism. Using a targeted proteomics approach, we screened renal protein extracts with rabbit polyclonal antibodies directed to each of the major Na transporters expressed along the nephron to determine whether escape from aldosterone-mediated Na retention is associated with decreased abundance of one or more of renal Na transporters. The analysis revealed that the renal abundance of the thiazide-sensitive Na-Cl cotransporter (NCC) was profoundly and selectively decreased. None of the other apical solute-coupled Na transporters displayed decreases in abundance, nor were the total abundances of the three ENaC subunits significantly altered. Immunocytochemistry showed a strong decrease in NCC labeling in distal convoluted tubules of aldosterone-escape rats with no change in the cellular distribution of NCC. Ribonuclease protection assays (RPAs) revealed that the decrease in NCC protein abundance was not associated with altered NCC mRNA abundance. Thus, the thiazide-sensitive Na-Cl cotransporter of the distal convoluted tubule appears to be the chief molecular target for regulatory processes responsible for mineralocorticoid escape, decreasing in abundance via a posttranscriptional mechanism.

Original languageEnglish (US)
Pages (from-to)215-222
Number of pages8
JournalJournal of Clinical Investigation
Volume108
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Member 3 Solute Carrier Family 12
Aldosterone
Kidney
Mineralocorticoids
Hyperaldosteronism
Nephrons
Extracellular Fluid
Ribonucleases
Proteomics
Proteins
Immunohistochemistry
Rabbits
Messenger RNA
thiazide receptor
Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. / Wang, Xiao Yan; Masilamani, Shyama; Nielsen, Jakob; Kwon, Tae Hwan; Brooks, Heddwen L; Nielsen, Søren; Knepper, Mark A.

In: Journal of Clinical Investigation, Vol. 108, No. 2, 2001, p. 215-222.

Research output: Contribution to journalArticle

Wang, Xiao Yan ; Masilamani, Shyama ; Nielsen, Jakob ; Kwon, Tae Hwan ; Brooks, Heddwen L ; Nielsen, Søren ; Knepper, Mark A. / The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. In: Journal of Clinical Investigation. 2001 ; Vol. 108, No. 2. pp. 215-222.
@article{2174db5f9d2245aaa92d23a298e439d0,
title = "The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon",
abstract = "The kidneys {"}escape{"} from the Na-retaining effects ofaldosterone when circulating levels of aldosterone are inappropriately elevated in the setting of normal or expanded extracellular fluid volume, e.g., in primary aldosteronism. Using a targeted proteomics approach, we screened renal protein extracts with rabbit polyclonal antibodies directed to each of the major Na transporters expressed along the nephron to determine whether escape from aldosterone-mediated Na retention is associated with decreased abundance of one or more of renal Na transporters. The analysis revealed that the renal abundance of the thiazide-sensitive Na-Cl cotransporter (NCC) was profoundly and selectively decreased. None of the other apical solute-coupled Na transporters displayed decreases in abundance, nor were the total abundances of the three ENaC subunits significantly altered. Immunocytochemistry showed a strong decrease in NCC labeling in distal convoluted tubules of aldosterone-escape rats with no change in the cellular distribution of NCC. Ribonuclease protection assays (RPAs) revealed that the decrease in NCC protein abundance was not associated with altered NCC mRNA abundance. Thus, the thiazide-sensitive Na-Cl cotransporter of the distal convoluted tubule appears to be the chief molecular target for regulatory processes responsible for mineralocorticoid escape, decreasing in abundance via a posttranscriptional mechanism.",
author = "Wang, {Xiao Yan} and Shyama Masilamani and Jakob Nielsen and Kwon, {Tae Hwan} and Brooks, {Heddwen L} and S{\o}ren Nielsen and Knepper, {Mark A.}",
year = "2001",
doi = "10.1172/JCI200110366",
language = "English (US)",
volume = "108",
pages = "215--222",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon

AU - Wang, Xiao Yan

AU - Masilamani, Shyama

AU - Nielsen, Jakob

AU - Kwon, Tae Hwan

AU - Brooks, Heddwen L

AU - Nielsen, Søren

AU - Knepper, Mark A.

PY - 2001

Y1 - 2001

N2 - The kidneys "escape" from the Na-retaining effects ofaldosterone when circulating levels of aldosterone are inappropriately elevated in the setting of normal or expanded extracellular fluid volume, e.g., in primary aldosteronism. Using a targeted proteomics approach, we screened renal protein extracts with rabbit polyclonal antibodies directed to each of the major Na transporters expressed along the nephron to determine whether escape from aldosterone-mediated Na retention is associated with decreased abundance of one or more of renal Na transporters. The analysis revealed that the renal abundance of the thiazide-sensitive Na-Cl cotransporter (NCC) was profoundly and selectively decreased. None of the other apical solute-coupled Na transporters displayed decreases in abundance, nor were the total abundances of the three ENaC subunits significantly altered. Immunocytochemistry showed a strong decrease in NCC labeling in distal convoluted tubules of aldosterone-escape rats with no change in the cellular distribution of NCC. Ribonuclease protection assays (RPAs) revealed that the decrease in NCC protein abundance was not associated with altered NCC mRNA abundance. Thus, the thiazide-sensitive Na-Cl cotransporter of the distal convoluted tubule appears to be the chief molecular target for regulatory processes responsible for mineralocorticoid escape, decreasing in abundance via a posttranscriptional mechanism.

AB - The kidneys "escape" from the Na-retaining effects ofaldosterone when circulating levels of aldosterone are inappropriately elevated in the setting of normal or expanded extracellular fluid volume, e.g., in primary aldosteronism. Using a targeted proteomics approach, we screened renal protein extracts with rabbit polyclonal antibodies directed to each of the major Na transporters expressed along the nephron to determine whether escape from aldosterone-mediated Na retention is associated with decreased abundance of one or more of renal Na transporters. The analysis revealed that the renal abundance of the thiazide-sensitive Na-Cl cotransporter (NCC) was profoundly and selectively decreased. None of the other apical solute-coupled Na transporters displayed decreases in abundance, nor were the total abundances of the three ENaC subunits significantly altered. Immunocytochemistry showed a strong decrease in NCC labeling in distal convoluted tubules of aldosterone-escape rats with no change in the cellular distribution of NCC. Ribonuclease protection assays (RPAs) revealed that the decrease in NCC protein abundance was not associated with altered NCC mRNA abundance. Thus, the thiazide-sensitive Na-Cl cotransporter of the distal convoluted tubule appears to be the chief molecular target for regulatory processes responsible for mineralocorticoid escape, decreasing in abundance via a posttranscriptional mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0034956918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034956918&partnerID=8YFLogxK

U2 - 10.1172/JCI200110366

DO - 10.1172/JCI200110366

M3 - Article

C2 - 11457874

AN - SCOPUS:0034956918

VL - 108

SP - 215

EP - 222

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -